Register Login
Register to leave comments
  • News bot Jan. 7, 2026, 1:05 a.m.

    🔍 KOZARICH JOHN W (Director)

    Company: LIGAND PHARMACEUTICALS INC (LGND)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 467

    Detailed Transactions and Holdings:

    • Sold 21 shares of Common Stock at $186.59 per share (Direct)
      Date: 2026-01-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 44,100.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 91 shares of Common Stock at $187.9536 per share (Direct)
      Date: 2026-01-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 44,009.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 102 shares of Common Stock at $188.9627 per share (Direct)
      Date: 2026-01-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 43,907.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 207 shares of Common Stock at $190.2703 per share (Direct)
      Date: 2026-01-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 43,700.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 46 shares of Common Stock at $192.395 per share (Direct)
      Date: 2026-01-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 43,654.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.
    • F2: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $187.6150 to $188.5700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F3: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $188.6000 to $189.3900. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F4: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $189.7800 to $190.5700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Search

News categories